Los Angeles, CANCT06322212Now EnrollingIRB Ready

Type2diabetes Clinical Trial in Los Angeles, CA

Access cutting-edge type2diabetes treatment through this early phase 1 clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by University of California, Los Angeles

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access type2diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related type2diabetes treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this type2diabetes clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Type2diabetes Study in Los Angeles

The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.

Sponsor: University of California, Los Angeles

Who Can Participate

Inclusion Criteria

Diagnosed T2DM
Outpatient status
Able to lay flat for imaging

Exclusion Criteria

A previous history of stroke
Current in-take of thiamine
Known thiamine allergy
Seizure disorder
Head trauma
Myocardial infarction
Current pregnancy (if female)
Diagnosed neuropsychiatric disorders (clinical depression, schizophrenia, manic-depression)
Diagnosed dementia
Sleep disordered breathing
Airway or chest deformities that would interfere with breathing
Chronic obstructive pulmonary disease
Cystic fibrosis
Presence of brain mass lesions
Any history of drug abuse (e.g., cocaine, tobacco, or cannabis)
Renal failure (requiring dialysis)
All T2DM adults with metallic and electronic implants (phrenic or cardiac pacemakers; although some pacemakers and cardioverter defibrillators are safe at a low magnetic field, they are not safe at 3.0-Tesla scanner)
Non-removable insulin pump/glucose sensor
Body weight more than 300 pounds (weight and height will be used to calculate BMI to determine if the patient will fit in the scanner and stay within parameters of size restrictions of MRI scanner table)
Any other contraindications to MRI, such as claustrophobia, or metallic-based tattoos, as per MRI safety website suggestions, will also be excluded.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT06322212) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type2diabetes Treatment Options in Los Angeles, CA

If you're searching for type2diabetes treatment options in Los Angeles, CA, this clinical trial (NCT06322212) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced type2diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type2diabetes clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Los Angeles, CA

See all pulmonary embolism clinical trials recruiting in Los Angeles — not just this study.

Browse Pulmonary Embolism Trials in Los Angeles →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA